Q4 2024 Earnings Call Transcript March 12, 2025 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.3, ...

Full Year 2024 Results Key Financial Results Revenue: US$92.1m (up 29% from FY 2023).

OptimizeRx Corp (OPRX) reports a 14% increase in fourth-quarter revenue and significant gross margin improvement, while transitioning to a subscription-based model for enhanced predictability.

OptimizeRx reports sales of $32.32M in Q4, beating consensus, with adjusted EPS of $0.30. Full-year revenue increased 29% and ...

Q4 2024 Results Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsSteve Silvestro - PresidentEdward ...

OptimizeRx (OPRX) delivered earnings and revenue surprises of 20% and 9.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Reports Q4 revenue $32.317M, consensus $30.36M. Stephen Silvestro, OptimizeRx (OPRX) CEO commented, “I’m incredibly proud of our strong fourth ...

Rep. Andrew Garbarino (R., N.Y.), chairman of the House Homeland Security Committee's subcommittee on cybersecurity and infrastructure protection, said the change in administration and leadership at ...

OptimizeRx (OPRX) has received a purported notice of nominations from a stockholder, Whetstone Capital Advisors, regarding its intention to ...

OptimizeRx (NASDAQ:OPRX – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect OptimizeRx to post earnings of $0.25 ...

While OptimizeRx Corporation ( NASDAQ:OPRX ) might not have the largest market cap around , it saw a double-digit ...